Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

EQUIVERM B PST DIN 00540765

Status: Cancelled Post Market
Holder: DAVIS AND LAWRENCE CO.
Molecule: MEBENDAZOLE

Health Canada record

Active ingredient(s)MEBENDAZOLE 100 MG; TRICHLORFON 459 MG
Dosage formPowder
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date31-Dec-1981
Current status date31-Jul-2002
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MEBENDAZOLE

DINProductCompanyFormStrengthStatus
00556734VERMOXJANSSEN INCTabletMEBENDAZOLE 100 MGMarketed
02243944BOT-PLUS SYRINGE FORMULA EQUINE WORMERCAN-VET ANIMAL HEALTH SUPPLIES LTD.PasteMEBENDAZOLE 100 MG; TRICHLORFON 459 MGDormant
00540773EQUIVERM 200MG/GMDAVIS AND LAWRENCE CO.PowderMEBENDAZOLE 200 MGCancelled Post Market
00755796TELMIN B SYRINGE FORMULAJANSSENPasteMEBENDAZOLE 100 MG; TRICHLORFON 459 MGCancelled Post Market
00755788TELMIN SYRINGE FORMULAJANSSEN PHARMACEUTICA N.V.PasteMEBENDAZOLE 200 MGCancelled Post Market
00889148WORM-AWAY IVSERGEANTS OF CANADATabletMEBENDAZOLE 100 MGCancelled Post Market

International API supply for MEBENDAZOLE

6 active FDA Drug Master Files.

Request a quote for EQUIVERM B PST

How to read a Canadian DIN record